Pure Global

Microferk 2 gram-negative bacteria drug Minka antibiotic-β-lactam combination - Taiwan Registration e9620edbbfb69767b20f8221777778e2

Access comprehensive regulatory information for Microferk 2 gram-negative bacteria drug Minka antibiotic-β-lactam combination in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number e9620edbbfb69767b20f8221777778e2 and manufactured by bioMérieux, Inc.. The authorized representative in Taiwan is BIOMERIEUX CHINA LIMITED, TAIWAN BRANCH (HONG KONG).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
e9620edbbfb69767b20f8221777778e2
Registration Details
Taiwan FDA Registration: e9620edbbfb69767b20f8221777778e2
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Microferk 2 gram-negative bacteria drug Minka antibiotic-β-lactam combination
TW: 微鐵克2革蘭氏陰性菌藥敏卡抗生素-β-內醯胺類組合類
Risk Class 2

Registration Details

e9620edbbfb69767b20f8221777778e2

DHA05603328900

Company Information

United States

Product Details

This product can be used with Microtek 2 automatic microbial analyzer to measure antibiotic susceptibility in clinical laboratories for clinically important aerobic gram-negative bacilli in vitro.

C Immunology and microbiology

C.1640 抗菌感受性試驗粉末

QMS/QSD;; 輸入

Dates and Status

Mar 13, 2020

Mar 13, 2025